After two failed attempts for bankruptcy protection, Johnson & Johnson faces at least 51,300 cases due to talc-related cancer claims. Earlier this year, Chris Schott, a JPMorgan Chase & Co. analyst, estimated J&J’s total talc liability at between $8 billion and $10 billion. As billions in settlement payments still loom over J&J’s head, the company is yet-again considering filing for bankruptcy a third time under Chapter 11 of the U.S. Bankruptcy Code in hopes of reaching a global settlement.
In the meantime, the litigation against J&J will continue to progress with MDL Bellwether Trials expected to begin in Fall 2024.
Shelby Roden filed one of the first federal talc lawsuits against J&J and will continue to monitor the ongoing litigation alleging claims related to ovarian cancer.
If you or a family member have been diagnosed with ovarian cancer, please contact our office at 205-933-8383 for a free consultation.